EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?

被引：0
|
作者：
Nisha Patel
Aruchuna Mohanaruban
Hutan Ashrafian
Carel Le Roux
James Byrne
John Mason
James Hopkins
Jamie Kelly
Julian Teare
机构：
[1] Imperial College London,St Mary’s Hospital
[2] Imperial College London,Metabolic Medicine, Charing Cross Hospital
[3] University Hospital Southampton NHS Foundation Trust,undefined
[4] Southampton General Hospital,undefined
[5] Trafford Hospitals,undefined
[6] Central Manchester University Hospitals NHS Foundation Trust,undefined
[7] North Bristol NHS Trust,undefined
[8] Southmead Hospital Bristol,undefined
来源：
Obesity Surgery | 2018年 / 28卷
关键词：
Obesity; Type 2 diabetes; Bariatric surgery; Bypass surgery; Duodenal-jejunal sleeve;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1980 / 1989
页数：9
相关论文
共 50 条
  • [1] ENDOBARRIER® : A SAFE AND EFFECTIVE NOVEL TREATMENT FOR OBESITY AND TYPE 2 DIABETES?
    Mohanaruban, A.
    Patel, N.
    Ashrafian, H.
    Stoenchev, K.
    Le Roux, C.
    Penney, N.
    Kelly, J.
    Byrne, J.
    Hopkins, J.
    Mason, J.
    Teare, J.
    GUT, 2017, 66 : A205 - A205
  • [2] EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
    Patel, Nisha
    Mohanaruban, Aruchuna
    Ashrafian, Hutan
    Le Roux, Carel
    Byrne, James
    Mason, John
    Hopkins, James
    Kelly, Jamie
    Teare, Julian
    OBESITY SURGERY, 2018, 28 (07) : 1980 - 1989
  • [3] EndoBarrier treatment for longstanding type 2 diabetes and obesity: outcomes one year after EndoBarrier in 90 consecutively treated patients
    Ryder, Robert E. J.
    Yadagiri, Mahi
    Burbridge, Wyn
    Irwin, Susan P.
    Gandhi, Hardeep
    Bashir, Tahira
    Allden, Rachael A.
    Wyres, Melanie
    Cull, Melissa
    Bleasdale, John P.
    Fogden, Edward N.
    Anderson, Mark R.
    Sen Gupta, Piya
    PRACTICAL DIABETES, 2022, 39 (03) : 13 - +
  • [4] Endobarrier treatment for longstanding type 2 diabetes and obesity: Outcomes one-year after endobarrier in 90 consecutively treated patients
    Ryder, R. E. J.
    Sen Gupta, P.
    Burbridge, W.
    Irwin, S. P.
    Bashir, T.
    Allden, R. A.
    Bleasdale, J. P.
    Fogden, E. N.
    Anderson, M. R.
    Yadagiri, M.
    DIABETIC MEDICINE, 2021, 38
  • [5] Treatment of Type 2 Diabetes: how effective and safe is Tirzepatide?
    Metzger, Leandra
    DIABETOLOGIE UND STOFFWECHSEL, 2021, 16 (06)
  • [6] Treatment of Type 2 Diabetes" How effective and safe is Tirzepatide? Comment
    Ritzel, Robert A.
    DIABETOLOGIE UND STOFFWECHSEL, 2021, 16 (06) : 454 - 455
  • [7] ENDOBARRIER DUODENO-JEJUNAL BYPASS LINER (ENDOSCOPIC TREATMENT OF TYPE II DIABETES AND OBESITY)
    Frydenberg, Harry
    OBESITY SURGERY, 2013, 23 (06) : 829 - 829
  • [8] Nateglinide added to metformin offers safe and effective treatment for type 2 diabetes
    Marre, M
    Whatmough, I
    Pongowski, M
    Guitard, C
    DIABETES, 2000, 49 : A361 - A361
  • [9] A UK cost-effectiveness analysis of the Endobarrier device in patients with Type 2 diabetes and obesity
    Armstrong, S.
    Sen Gupta, P.
    Amiel, S. A.
    Drummond, R. S.
    McGowan, B. M.
    Ryder, R. E. J.
    Pennington, M. W.
    DIABETIC MEDICINE, 2018, 35 : 169 - 170
  • [10] Endobarrier treatment for longstanding type 2 diabetes and obesity: A comparison of the outcomes with an implantation period of 9 months versus 12 months in 90 consecutive EndoBarrier treated patients
    Ryder, R. E. J.
    Yadagiri, M.
    Burbridge, W.
    Irwin, S. P.
    Bashir, T.
    Allden, R. A.
    Bleasdale, J. P.
    Fogden, E. N.
    Anderson, M. R.
    Sen Gupta, P.
    DIABETIC MEDICINE, 2023, 40
12345